BMNR three-lens brief
Evidence-based stock research on BMNR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 42.0pp over 30 days. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Outperforming SPY by 42.0pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $44.53 — 84% above current (3 analysts).
- Negative free cash flow last quarterly (-$518.10M).
- 8-K filing filed 2026-08-31.
BMNR closed at $24.20 (-0.04%) as of 2026-09-11. Market cap: $14.60B. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 42.0pp over 30 days.; analyst mean target $44.53 — 84% above current (3 analysts).. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.; negative free cash flow last quarterly (-$518.10M).. Last quarter: Revenue $46.53M, net income -$83.58M, free cash flow -$518.10M.
Why three lenses on BMNR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BMNRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BMNR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BMNR brief"></iframe>